#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Synovitis Infertility female Paroxysmal nocturnal haemoglobinuria Scedosporium infection Bone marrow disorder Soft tissue sarcoma Hypochondroplasia Univentricular heart Medullary thyroid cancer Angiosarcoma Metastases to central nervous system Amyotrophic lateral sclerosis Thrombotic microangiopathy Laryngeal squamous cell carcinoma Infertility male More trials…

    Learn about Rare Diseases

    Leiomyosarcoma – Basic Information Pituitary-dependent Cushing’s syndrome – Diagnostics Tuberous sclerosis complex – Trials in Disease Niemann-Pick disease – Treatment Loeys-Dietz syndrome Haemophilia A without inhibitors – Life with Disease Mucopolysaccharidosis II – Life with Disease Marfan’s syndrome – Diagnostics Factor IX deficiency – Diagnostics Progressive multifocal leukoencephalopathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Triglycerides, Medium Chain Arachis Hypogaea Flour Valiltramiprosate Entecavir Opevesostat Tosilate Estriol Ranolazine Interferon Beta-1A Specific Nucleic Acid Sna-Xfsc Pal1-15 Acetate Acp-204 Tartrate RNMB1 Ammonium Chloride Bp Empagliflozin 12 Grass Pollen Mixture Olaptesed Pegol Valproate Semisodium Ds-2325A C1 Esterase Inhibitor (Human) Protein C More therapies…

    Learn about Your Condition

    Perinatal depression Vulvovaginal pruritus Bladder cancer stage II Gestational diabetes Coronary artery occlusion Liposarcoma recurrent Insulin resistance Laparotomy Endometrial cancer stage I Benign renal neoplasm Diabetic retinal oedema Liver disorder Tympanic membrane perforation Arrhythmia Transient ischaemic attack More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Behavior and Behavior Mechanisms

  • Study on the Effectiveness of Reconsolidation Therapy with Propranolol for Patients with Severe Post-Traumatic Stress Disorder

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Propranolol Hydrochloride
    Belgium

  • Propranolol hydrochloride dose-finding trial to reduce reactive aggression in patients with reactive aggression

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Propranolol Hydrochloride
    The Netherlands

  • Cognitive effects of a three‑month methylphenidate course in Parkinson’s disease patients with mild cognitive impairment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    Spain

  • Microdosing lysergide (20 µg) to improve symptoms, emotion regulation and sleep in adults with ADHD

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    Investigated Drugs:
    • LYSERGIDE
    The Netherlands

  • Testing Psilocybin with Therapy for Treatment of Gambling Disorder in Adults with Problem Gambling

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Hypromellose
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    France

  • A Study Testing How Ropinirole Affects Self-Assessment of Thinking Performance and Brain Activity in Healthy Volunteers

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    • ROPINIROLE
    Italy
Previous Page
1 2 3 4 5 6 … 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!